http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-35059-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 1971-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-35059-L |
| titleOfInvention | New halogeno-steroids. |
| abstract | 1329207 21-Fluoro-16,17-dihydroxy-pregnanes and their derivatives CIBA-GEIGY AG 19 April 1971 [17 April 1970] 9796/71 Heading C2U Novel steroids of the formula (wherein X is F or Cl and R, R 1 and R 2 are each free, esterified or etherified OH groups or R 1 and R 2 together are O-C (=Z)-O where Z is 2 aliphatic, aromatic or araliphatic hydrocarbon radicals which may be the same or different or # C = Z is a cyoloalkylidene group) are prepared by reduction of the corresponding 3-ones. Products may be hydrolysed, esterified, etherified or ketalized. The novel steroids are stated to possess gestagenic, ovulation-inhibiting and anti-inflammatory action, and they may be made up into pharmaceutical compoitions with suitable carriers. Specifications 1,320,301 and 1,320,302 are referred to.n[GB1329207A] |
| priorityDate | 1970-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.